Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Uncertainty: Confidence Intervals00:54

Uncertainty: Confidence Intervals

The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Confidence Coefficient01:24

Confidence Coefficient

The confidence coefficient is also known as the confidence level or degree of confidence. It is the percent expression for the probability, 1-α, that the confidence interval contains the true population parameter assuming that the confidence interval is obtained after sufficient unbiased sampling; for example, if the CL = 90%, then in 90 out of 100 samples the interval estimate will enclose the true population parameter. Here α is the area under the curve, distributed equally under both the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A hierarchical network model for the estimate of the energy expenditure in individuals with type 1 diabetes.

Engineering applications of artificial intelligence·2026
Same author

Biological sex influences immune response to influenza infection in juvenile outbred mice.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.

Journal of diabetes science and technology·2026
Same author

Mathematical Model of Influenza Infection Suggests JAK-STAT Activity Drives Severe Pathologies in Juvenile Mice.

Frontiers in applied mathematics and statistics·2026
Same author

Human neuromuscular organoids mimic cancer-induced muscle cachexia.

Cell reports methods·2026
Same author

Autoregressive With Exogenous Input (ARX) Decision Support for Blood Pressure Maintenance During Cesarean Delivery Under Spinal Anesthesia: A Prospective Pilot Study With Matched Nonconcurrent Controls.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jun 6, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Confidence from uncertainty--a multi-target drug screening method from robust control theory.

Camilla Luni1, Jason E Shoemaker, Kevin R Sanft

  • 1Department of Chemical Engineering, University of California, Santa Barbara, CA 93106-5080, USA.

BMC Systems Biology
|November 26, 2010
PubMed
Summary

Robust control theory, using Structured Singular Value (μ-analysis), identifies effective multi-drug therapies by leveraging robustness against system uncertainty. This approach aids in designing treatments for complex diseases like cancer and diabetes.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Systems biology
  • Computational biology
  • Pharmacology

Background:

  • Biological systems exhibit robustness, a defense against environmental variability.
  • Complex diseases hijack these robust mechanisms for survival.
  • Single-drug therapies often fail against disease robustness; multi-drug therapies can restore disrupted networks.

Purpose of the Study:

  • To apply robust control theory to identify effective multi-drug therapies.
  • To utilize robustness against uncertainty as a target discrimination method.
  • To address combinatorial challenges in multi-drug therapeutic design.

Main Methods:

  • Application of Structured Singular Value (μ-analysis) from robust control theory.
  • Identification of synergistic targets robust to system uncertainty.
  • Case study using a negative feedback network motif with parametric uncertainty.

Main Results:

  • Demonstrated μ-analysis for identifying highly effective multi-drug therapies.
  • Showcased robustness against uncertainty as a novel target discrimination criterion.
  • Illustrated the method's application in a biological network model.

Conclusions:

  • Contributes effective methods for drug screening in network modeling with parametric uncertainty.
  • Results are applicable to various uncertainty sources, including data noise and biological variability.
  • Provides a framework for designing robust multi-drug therapies for complex diseases.